HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.11
-0.03 (-0.96%)
▼
5d:
+5.07%
30d:
-15.95%
90d:
-4.89%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HYPD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HYPD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.85
Based on -20.5% avg growth
INTRINSIC VALUE TODAY
$0.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.11, which is considered fair relative to its 30-day fair value range of $2.88 to $3.63. The stock's valuation (Forward PE: 7.2) is in line with its historical norms (6.9). At these levels, the market is pricing in 1.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.95 (+123.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05.
Market Sentiment: HYPD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.95 (+123.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.88 -
$3.63
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 123.5% below Wall St target ($6.95)
- NEUTRAL: Market pricing in 1.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$2.88 -
$3.63
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$4.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.15
Wall Street Target
$6.95
(+123.5%)
Revenue Growth (YoY)
1559.5%
Valuation Premium vs History
+1.0% premium
PE vs Historical
7.2 vs 6.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$3.14
(+1%)
2-Year Target
$3.17
(+2%)
3-Year Target
$3.20
(+3%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$3.09
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -44.9%)
$6.91
(+122%)
Base:
(SPY PE: 7.1, Growth: -44.9%)
$2.27
(-27%)
Bear:
(PE: 6.1, Growth: -44.9%)
$1.93
(-38%)
Share & Embed Analysis
Last updated: July 03, 2026 9:07 PM ET
Data refreshes hourly during market hours. Next update: 10:07 PM
Data refreshes hourly during market hours. Next update: 10:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
